Answers are grounded in this paper and cite their sources.
For over two decades now, plants have been explored for their potential to act as production platforms for biopharmaceuticals, such as vaccines and monoclonal antibodies. More recently, plant viruses have been designed as nontoxic nanoparticles that can target a variety of cancers and thus empower the immune system to slow or even reverse tumor progression. The following paper describes the employment of plant virus expression vectors for the treatment of some of the most challenging diseases known today. The paper concludes with a projection of the multiple avenues by which virus nanoparticles could impact developing countries.
No takes yet. Share an insight, caveat, or question.
Kathleen Hefferon (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: